Abstract:Objective To investigate expression of microRNA-944 (miR-944) in patients with endometrial carcinoma (EC), and to determine its clinical significance. Methods The expression level of miR-944 in 80 cases of EC cancer tissues and 30 cases of normal endometrial tissues were measured by real-time quantitative fluorescence PCR (real-time PCR) test. Relationship between the expression of miR-944 and the clinical characteristics of patients with EC was analyzed. Results RT-PCR showed that the expression level of miR-944 in EC cancer tissue was significantly higher than that in normal endometrium (P < 0.05). Expression of miR-944 was correlated to the depth of tumor myometrium infiltration, lymph node metastasis, distant metastasis and FIGO stage (P < 0.05). Log-rank test showed that the survival time of the patients with high expression of miR-944 was decreased obviously compared with that in patients with low expression group of miR-944 (P < 0.05). ROC analysis showed that the area under the curve of miR-944 (AUC) was 0.784. No obvious correlation was identified between miR-944 and age, menopausal status, pathological classification, or histological grade (P > 0.05). Conclusions High expression of miR-944 in EC cancer tissue relates to the poor prognosis, which may be used as a potential diagnostic and prognostic biomarker.